Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis Group 2021-01-01
Serie:mAbs
Soggetti:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
Accesso online:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi